These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
193 related items for PubMed ID: 29890239
1. A trial of type 12 purinergic (P2Y12) receptor inhibition with prasugrel identifies a potentially distinct endotype of patients with aspirin-exacerbated respiratory disease. Laidlaw TM, Cahill KN, Cardet JC, Murphy K, Cui J, Dioneda B, Kothari P, Raby BA, Israel E, Boyce JA. J Allergy Clin Immunol; 2019 Jan; 143(1):316-324.e7. PubMed ID: 29890239 [Abstract] [Full Text] [Related]
2. Trial of thromboxane receptor inhibition with ifetroban: TP receptors regulate eicosanoid homeostasis in aspirin-exacerbated respiratory disease. Laidlaw TM, Buchheit KM, Cahill KN, Hacker J, Cho L, Cui J, Feng C, Chen CC, Le M, Israel E, Boyce JA. J Allergy Clin Immunol; 2023 Sep; 152(3):700-710.e3. PubMed ID: 37068712 [Abstract] [Full Text] [Related]
6. Effect of prasugrel in patients with asthma: results of PRINA, a randomized, double-blind, placebo-controlled, cross-over study. Lussana F, Di Marco F, Terraneo S, Parati M, Razzari C, Scavone M, Femia EA, Moro A, Centanni S, Cattaneo M. J Thromb Haemost; 2015 Jan; 13(1):136-41. PubMed ID: 25387888 [Abstract] [Full Text] [Related]
9. Omalizumab for Aspirin Hypersensitivity and Leukotriene Overproduction in Aspirin-exacerbated Respiratory Disease. A Randomized Controlled Trial. Hayashi H, Fukutomi Y, Mitsui C, Kajiwara K, Watai K, Kamide Y, Nakamura Y, Hamada Y, Tomita Y, Sekiya K, Tsuburai T, Izuhara K, Wakahara K, Hashimoto N, Hasegawa Y, Taniguchi M. Am J Respir Crit Care Med; 2020 Jun 15; 201(12):1488-1498. PubMed ID: 32142372 [Abstract] [Full Text] [Related]
13. The influence of smoking status on the pharmacokinetics and pharmacodynamics of clopidogrel and prasugrel: the PARADOX study. Gurbel PA, Bliden KP, Logan DK, Kereiakes DJ, Lasseter KC, White A, Angiolillo DJ, Nolin TD, Maa JF, Bailey WL, Jakubowski JA, Ojeh CK, Jeong YH, Tantry US, Baker BA. J Am Coll Cardiol; 2013 Aug 06; 62(6):505-12. PubMed ID: 23602770 [Abstract] [Full Text] [Related]
14. Omalizumab can inhibit respiratory reaction during aspirin desensitization. Lang DM, Aronica MA, Maierson ES, Wang XF, Vasas DC, Hazen SL. Ann Allergy Asthma Immunol; 2018 Jul 06; 121(1):98-104. PubMed ID: 29777744 [Abstract] [Full Text] [Related]
16. Increased platelet inhibition after switching from prasugrel to low-dose ticagrelor in Japanese patients with prior myocardial infarction. Tateishi K, Saito Y, Kitahara H, Nakayama T, Fujimoto Y, Kobayashi Y. J Cardiol; 2020 May 06; 75(5):473-477. PubMed ID: 31718953 [Abstract] [Full Text] [Related]
17. Induced sputum eicosanoids during aspirin bronchial challenge of asthmatic patients with aspirin hypersensitivity. Mastalerz L, Celejewska-Wójcik N, Wójcik K, Gielicz A, Januszek R, Cholewa A, Stręk P, Sanak M. Allergy; 2014 Nov 06; 69(11):1550-9. PubMed ID: 25123806 [Abstract] [Full Text] [Related]
18. Insights from In Vitro and Clinical Data to Guide Transition from the Novel P2Y12 Antagonist Selatogrel to Clopidogrel, Prasugrel, and Ticagrelor. Schilling U, Dingemanse J, Dobrow M, Baumann M, Riederer MA, Juif PE, Ufer M. Thromb Haemost; 2021 Jun 06; 121(6):755-766. PubMed ID: 33412611 [Abstract] [Full Text] [Related]